

(Sharecast News) - Barclays upgraded Dr Martens to 'overweight' from 'equalweight' on Wednesday, keeping the price target at 480p, as it argued that t...


Dr Martens trading slightly ahead of expectations in first quarter


(Sharecast News) - Iconic boot maker Dr Martens said on Thursday that revenues jumped in the first quarter, with trading "slightly" ahead of its expec...


(Sharecast News) - Dr Martens: Goldman Sachs upgrades to buy with a target price of 535p.


(Sharecast News) - Goldman Sachs upped Dr Martens to 'buy' from 'neutral' on Tuesday, hiking the price target to 535p from 490p.


DIRECTOR DEALINGS: GB Group chair buys shares; SolGold director sells


(Sharecast News) - Dr Martens revealed on Monday that non-executive director Robyn Perriss had acquired 20,000 ordinary shares in the FTSE 250-listed ...


TOP NEWS: Dr Martens profit down as listing costs offset revenue hike